Prevalence of depressive symptoms among non insulin treated Greek type 2 diabetic subjects

被引:16
作者
Sotiropoulos A. [1 ]
Papazafiropoulou A. [1 ]
Apostolou O. [1 ]
Kokolaki A. [1 ]
Gikas A. [2 ]
Pappas S. [1 ]
机构
[1] 3rd Department of Internal Medicine, Center of Diabetes, General Hospital of Nikaia Saint Panteleimon, Piraeus
[2] Department of General Practice, Health Centre of Kalivia, Kalivia-Lagonisi, Athens
关键词
Depressive Symptom; Beck Depression Inventory; Diabetic Subject; Poor Glycemic Control; Macrovascular Disease;
D O I
10.1186/1756-0500-1-101
中图分类号
学科分类号
摘要
Background. Depression is common among diabetic subjects. We conducted the present study to estimate the prevalence of depression in subjects with type 2 diabetes (T2D) in Greece. Methods. The study sample consisted of 320 T2D subjects without overt macrovascular disease attending the diabetes outpatient clinic of our hospital, from June 2007 to December 2007. Depressive symptoms were measured using the 21-item Beck Depression Inventory, modified for use in diabetic subjects. Results. Of the study subjects 107 (33.4%) reported elevated depressive symptoms. More women than men with diabetes reported symptoms of depression (48.4% vs. 12.7%, P < 0.001). In the female study group, depressive symptoms were correlated with HbA1c(P = 0.04), and duration of diabetes (P = 0.004). In the male study group, univariate linear regression analysis showed no significant relationships between depressive symptoms and the testing variables. Conclusion. The prevalence of depression in Greek T2D subjects is high. Diabetic female subjects showed increased levels of depressive symptoms compared with male subjects. Independent risk factors of depressive symptoms in diabetic female subjects were diabetes duration and glycemic control. © 2008 Sotiropoulos et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 37 条
[21]  
Ali S., Stone M.A., Peters J.L., Davies M.J., Khunti K., The prevalence of co-morbid depression in adults with Type 2 diabetes: A systematic review and meta-analysis, Diabet Med, 23, pp. 1165-1173, (2006)
[22]  
Goldney R.D., Phillips P.J., Fisher L.J., Wilson D.H., Diabetes, depression and quality of life. A population based study, Diabetes Care, 27, pp. 1066-1070, (2004)
[23]  
Pibermik-Okanovic M., Peros K., Szabo S., Begic D., Metelko Z., Depression in Croatian Type 2 diabetic patients: Prevalence and risk factors. A Croatian survey from the European Depression in Diabetes (EDID) Research Consortium, Diabet Med, 22, pp. 942-945, (2005)
[24]  
Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J., The prevalence of comorbid depression in adults with diabetes: A meta-analysis, Diabetes Care, 24, pp. 1069-1078, (2001)
[25]  
Piccinelli M., Wilkinson G., Gender differences in depression, Br J Psychiatry, 177, pp. 486-492, (2000)
[26]  
Carney R.M., Freedland K.E., Sheline Y.I., Weiss E.S., Depression and coronary heart disease: A review for cardiologists, Clin Cardiol, 20, pp. 196-200, (1997)
[27]  
Bottomly A., Depression in cancer patients: A literature review, Eur J Cancer Care, 7, (1998)
[28]  
Culbertson F.M., Depression and gender: An international review, Am Psychol, 52, pp. 25-31, (1997)
[29]  
Archer J.S., Relationship between estrogen, serotonin, and depression, Menopause, 6, pp. 71-78, (1999)
[30]  
Arroyo C., Hu F.B., Ryan L.M., Kawachi I., Colditz G.A., Speizer F.E., Manson J., Depressive Symptoms and Risk of Type 2 Diabetes in Women, Diabetes Care, 27, 1, pp. 129-133, (2004)